Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG32468

GNG12 Knockout SK-HEP-1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Liver

  • Disease:

    Adenocarcinoma

The GNG12 Knockout SK-HEP-1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population derived from the SK-HEP-1 hepatic endothelial cell line. This model features targeted disruption of the GNG12 gene, which encodes a G protein gamma subunit critical for GPCR signal transduction, providing a versatile platform for studying GPCR pathways in liver sinusoidal endothelial cells. Knockout of GNG12 impairs G?¦?-dependent activation of downstream effectors including ERK1/2 and AKT, affecting proliferation, migration, and survival. These cells enable investigation of GNG12-specific roles in sinusoidal function, inflammation, and tumor-endothelial interactions, supporting applications in angiogenesis research, hepatocellular carcinoma studies, and GPCR-targeted drug screening.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    SK-HEP-1

    Sex of Donor

    Male

    Age

    52 years

    Gene Name

    GNG12

    Gene Identifier

    NCBI Gene ID 55970

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    MEM (with NEAA)

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The GNG12 Knockout SK-HEP-1 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout population targeting the GNG12 gene, which encodes the gamma 12 subunit of heterotrimeric G proteins. This product comprises a heterogeneous pool of SK-HEP-1 cells harboring disruptions at the GNG12 locus, enabling loss-of-function studies without clonal isolation. The polyclonal format retains natural biological variability and is well suited for biochemical, signaling, and phenotypic assays where population-level knockout effects are desired.

The parental SK-HEP-1 cell line was derived from the ascitic fluid of a patient with liver adenocarcinoma and has since been characterized as a liver sinusoidal endothelial cell (LSEC) model. These cells exhibit hallmark endothelial features, including fenestrae formation and scavenger activity, and respond to angiogenic and inflammatory stimuli. SK-HEP-1 provides a relevant in vitro system for investigating hepatic sinusoidal function, tumor angiogenesis, and the microenvironment of hepatocellular carcinoma.

GNG12 is an essential component of the G?¦? dimer that transduces signals from G protein-coupled receptors (GPCRs) to intracellular effectors. In SK-HEP-1 cells, GNG12 associates with G?? subunits like GNB1 and couples to G?? proteins such as GNAQ. Upon receptor activation by ligands including LPA, S1P, and chemokines, the G?¦? complex stimulates PLC-?? and receptor kinases, leading to phosphorylation of ERK1/2 (MAPK3) and AKT (AKT1), activation of Rho GTPases, and regulation of integrin-mediated adhesion. These pathways control critical endothelial functions including proliferation, migration, and survival.

Disruption of GNG12 in this polyclonal population abrogates formation of functional G?¦? dimers, thereby uncoupling GPCR activation from downstream ERK and AKT signaling. The resulting loss of signal transduction impairs GPCR-driven endothelial cell proliferation, migration, and survival, providing a clear loss-of-function model for studying G??12-dependent biology. As SK-HEP-1 cells retain key LSEC characteristics, the knockout phenotype reveals contributions of G??12 to hepatic endothelial pathophysiology without interference from other gamma subunits. This system enables dissection of GNG12-specific roles in LSEC functions such as sinusoidal permeability, angiogenesis, and inflammatory responses, with particular relevance to hepatocellular carcinoma progression.

Researchers can employ the GNG12 Knockout SK-HEP-1 Polyclonal Cells in diverse experimental workflows, including western blotting for phospho-ERK and phospho-AKT, RT-qPCR analysis of downstream gene expression, and transwell migration or invasion assays to assess angiogenic and metastatic behaviors. These cells are particularly valuable for studying GPCR signaling in the liver endothelium, screening compounds that target G?¦?-mediated pathways, and investigating the role of GNG12 in inflammation-associated hepatocellular carcinoma. For additional product details or to inquire about pricing, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)